🕵️ Femasys Inc ($FEMY)
SEC insider & ownership activity, last 12 months · CIK 1339005 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. Dauntless Investment Group, LLC added 5.4% → 9.9%; Chernett Jorey added 6.2% → 9.3%. One red-flag 8-K in the window: Delisting notice (3.01), Jan 13, 2026.
Insider flow
5 buyers, value withheld pending verification (5 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Canning John Charles | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Elefant Dov | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Lee-Sepsick Kathy | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Sipos Jeremy Alexander | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Mifek Jeffrey Gerald | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alumni Capital LP | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Alumni Capital GP LLC | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Ashkan Mapar | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Nantahala Capital Management, LLC | 10.0% | 13D | Aug 10, 2026 | filing ↗ | |
| Wilmot B. Harkey | 10.0% | 13D | Aug 10, 2026 | filing ↗ | |
| Daniel Mack | 10.0% | 13D | Aug 10, 2026 | filing ↗ | |
| Nantahala Capital Partners Limited Partnership | 10.0% | 13D | Aug 10, 2026 | filing ↗ | |
| Dauntless Investment Group, LLC | 9.9% | 13G | Nov 14, 2025 | filing ↗ | |
| Rosalind Advisors, Inc. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Salamon Steven A. J. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Aharon Gil | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Rosalind Master Fund L.P. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Chernett Jorey | 9.3% | 13G | Aug 5, 2025 | filing ↗ | |
| PharmaCyte Biotech, Inc. | 7.9% | 13G | Mar 18, 2026 | filing ↗ | |
| Stonepine Capital Management, LLC | 7.2% | 13G | Aug 31, 2026 | filing ↗ | |
| Stonepine Capital, L.P. | 7.2% | 13G | Aug 31, 2026 | filing ↗ | |
| Stonepine GP, LLC | 7.2% | 13G | Aug 31, 2026 | filing ↗ | |
| Jon M. Plexico | 7.2% | 13G | Aug 31, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Other events (8.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |